NFL Biosciences Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2021	FY 2020
Period Ending	Jan '26 Jan 9, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	17	19	12	13	-
Market Cap Growth	-11.58%	63.78%	-7.08%	-	-
Enterprise Value	15	16	9	-	-
Last Close Price	1.33	1.97	1.44	2.40	-
PS Ratio	103077.87	415647.00	58.37	322129.97	-
PB Ratio	-	19.58	33.36	3.82	-
P/TBV Ratio	-	23.00	55.88	3.97	-
EV/Sales Ratio	-	347824.17	42.77	-	-
Debt / Equity Ratio	-	0.04	0.18	0.03	0.57
Quick Ratio	-	2.23	1.54	18.44	5.22
Current Ratio	-	2.35	1.61	19.16	5.22
Return on Equity (ROE)	-	-313.76%	-	-56.92%	-
Return on Assets (ROA)	-	-46.01%	-	-26.45%	-
Return on Capital (ROIC)	-	-243.97%	-	-31.25%	-
Return on Capital Employed (ROCE)	-	-127.60%	-263.90%	-25.80%	-65.30%
Earnings Yield	-18.65%	-10.88%	-32.09%	-7.79%	-
Buyback Yield / Dilution	-	-23.79%	-55.89%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.